Washington Trust’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-167
| Closed | -$500 | – | 839 |
|
2023
Q3 | $500 | Hold |
167
| – | – | ﹤0.01% | 878 |
|
2023
Q2 | $5.15K | Hold |
167
| – | – | ﹤0.01% | 703 |
|
2023
Q1 | $8.25K | Hold |
167
| – | – | ﹤0.01% | 677 |
|
2022
Q4 | $4.1K | Hold |
167
| – | – | ﹤0.01% | 744 |
|
2022
Q3 | $11K | Hold |
167
| – | – | ﹤0.01% | 632 |
|
2022
Q2 | $7K | Hold |
167
| – | – | ﹤0.01% | 683 |
|
2022
Q1 | $8K | Hold |
167
| – | – | ﹤0.01% | 690 |
|
2021
Q4 | $10K | Hold |
167
| – | – | ﹤0.01% | 665 |
|
2021
Q3 | $8K | Hold |
167
| – | – | ﹤0.01% | 797 |
|
2021
Q2 | $10K | Hold |
167
| – | – | ﹤0.01% | 778 |
|
2021
Q1 | $10K | Hold |
167
| – | – | ﹤0.01% | 755 |
|
2020
Q4 | $11K | Hold |
167
| – | – | ﹤0.01% | 739 |
|
2020
Q3 | $42K | Hold |
167
| – | – | ﹤0.01% | 474 |
|
2020
Q2 | $28K | Hold |
167
| – | – | ﹤0.01% | 493 |
|
2020
Q1 | $12K | Buy |
+167
| New | +$12K | ﹤0.01% | 638 |
|
2018
Q3 | – | Sell |
-167
| Closed | -$10K | – | 283 |
|
2018
Q2 | $10K | Buy |
+167
| New | +$10K | ﹤0.01% | 670 |
|